Trial Profile
Phase I trial of biosimilar trastuzumab in patients with breast cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Aug 2015
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- Sponsors PlantForm Corporation
- 07 Aug 2015 New trial record